Nicotine pouches were authorized in Canada as smoking cessation products intended to support adult smokers in quitting. Products making health and cessation claims should remain connected to healthcare oversight and evidence-based smoking cessation support.

Pharmacists are uniquely positioned to provide counselling, patient guidance, and continuity of care in ways that general retail environments cannot.

Restricting nicotine pouch sales to pharmacies was the right public health decision. Pharmacy-only access helps reinforce the positioning of nicotine pouches as smoking cessation tools rather than general consumer nicotine products.

Maintaining pharmacy oversight supports responsible adult access while reducing normalization within convenience retail environments.

Canada’s experience with vaping demonstrated how quickly alternative nicotine products can outpace regulatory frameworks when commercialization occurs faster than oversight and enforcement.

Strong safeguards, controlled access environments, and healthcare supervision are critical to reducing youth exposure and preventing nicotine products from becoming normalized among non-smokers.

The rapid growth of illicit and unregulated nicotine pouch sales through convenience stores, online marketplaces, and social media channels is undermining the integrity of Canada’s regulatory framework.

Governments should prioritize stronger federal and provincial enforcement coordination targeting unauthorized sales channels.

Smoking cessation products are most effective when combined with counselling, behavioural support, and healthcare-provider involvement.

Nicotine regulation should prioritize evidence-based public health approaches that balance smoking cessation objectives with youth protection.

Pharmacists are frontline healthcare professionals with an established role in smoking cessation support, nicotine replacement guidance, and patient education.

As one of the only nicotine-related product categories currently restricted exclusively to pharmacies, nicotine pouches represent an important opportunity to reinforce the role of pharmacy within smoking cessation and harm reduction care.